Lung Cancer | Oncology Today with Dr Neil Love: Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations

Research To Practice | Oncology Videos

Featuring an interview with Dr Roy S Herbst, including the following topics:

• Localized Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation (0:00)
• Phase III ADAURA Trial — Study Design and Characteristics of Enrolled Patients (3:32)
• Efficacy Data from the Phase III ADAURA Study Evaluating Adjuvant Osimertinib in Resected NSCLC with an EGFR Mutation (8:07)
• Tolerability and Toxicity of Osimertinib in the ADAURA Trial; Impact of Adjuvant Chemotherapy on Disease-Free Survival Outcomes (15:17)
• FDA Approval of Osimertinib as Adjuvant Therapy in Early-Stage NSCLC with an EGFR Mutation; Future Direction of Clinical Research (23:13)

CME information and select publications